Error: Could not add to watchlist. X
+ Watchlist

Bellerophon Therapeutics Inc

6L7:GR
Frankfurt
1.29
EUR
0.04
3.28%
As of 9:32 AM EDT 6/26/2017
Open
1.28
Day Range
1.28 - 1.29
Volume
0
Previous Close
1.25
52Wk Range
0.94 - 1.46
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
1.28
Day Range
1.28 - 1.29
Volume
0
Previous Close
1.25
52Wk Range
0.94 - 1.46
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (m EUR)
45.170
Shares Outstanding (m)
34.989
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.16%
% Price Change
-0.36%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Bellerophon Therapeutics Inc is a biotherapeutics company. The Company develops medical devices and drugs for the healtchcare industry, and primarily for cardiac related diseases.
Address
53 Frontage Road
Suite 301
Hampton, NJ 08827
United States
Phone
1-908-574-4770
  • Jonathan M Peacock
    Chairman
  • Fabian Tenenbaum
    Chief Executive Officer
  • Peter Fernandes
    Chief Regulatory & Safety Ofcr
  • Deborah A Quinn
    VP/Chief Medical Officer
  • Amy Edmonds
    VP:Clinical Ops & Administration
Show More